Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • TradeFlock Reveals Its List of 10 Best COOs in India 2026 Lifestyle
  • Canvas of Achievement: Stories of Ten Dynamic Women Redefining Excellence Lifestyle
  • Earneasy24: Empowering Users with Innovative IT Solutions Business
  • Utssav CZ Gold Jewels Reports 136% PAT Growth and PAT Margin Expansion of 123 Bps in FY26 Business
  • Best Crypto Presale: AlphaPepe Nears Total Sell Out After Crushing Stage 19 and Passing $2.3 Million Business
  • Fayazoddin Mohamad – A Seasoned Expert in Regulatory Compliance and Pharmacy Management Education
  • Prem Dhiraal is going to become a hero from zero in Bollywood Lifestyle
  • Mynampally Hanumanth Rao: Congress Turns to a Veteran in Jubilee Hills National

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Building the Future of Steel: MPK Steels Enhances Capacity with Automation and Solar Expansion Business
  • Tired of Cleaning Gmail Inbox? Happy Inbox Might Be Your New Favorite App  Business
  • On The Occasion Of Its 13th Anniversary, Shyam Advisory – Investment Advisor Reveals Ambitious Long-Term Goals Business
  • IntelligentDX Launches Smart AI-Powered Software to Transform US Healthcare and RCM with Intelligent EHR/EMR Business
  • Angie Homes Unveils Exquisite Soft Furnishings Collection Business
  • Balu Forge Industries Ltd. Announces Q1FY25 Financial Results, PAT rises 104.96% to ₹341.67 Mn Business

Recent Posts

  • Global Experts Deliberate on Democracy in the Age of AI at DSVV
  • Prime Car Care Is Changing How People Discover PPF — Before the Damage, Not After
  • Dyslexia Symptoms in Children Often Mistaken for Laziness, Says Indore based Child Psychologist Dr Vini — Here’s What Parents Should Know Before Exam Season
  • Signoff Launches Enterprise Agentic AI Intelligence Platform
  • Captain Polyplast Secures Rs 47 Cr Order from MSEDCL for 2,000 Solar Pumps

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • SUD Life Launches New ULIP Funds to Play the India Growth Story and Create Wealth for Policyholders Finance
  • “Sheros Shakti Samman” to Dr. Neha Sharma Chowdhury Business
  • Indcap Advisors participated in the Investment Yatra, an initiative of CII Eastern Region in the capacity of a facilitator. Business
  • Finda India’s Visionary Approach Revolutionizes B2B Trading Norms Through Innovative E-commerce Platform Business
  • A Royal Journey: In Conversation with Rajkumar Dhushyant Anil Lifestyle
  • Mohammad Jamaluddin to Join Jan Suraaj Launch, Backs Prashant Kishore’s Vision for Bihar National
  • Let’s Cook With Sonal: A Beginner’s Haven For Learning Best Tips For Baking & Cooking At Home Lifestyle
  • World’s #1 Regulated Cryptocurrency PNP COIN is ready to conquer the world Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme